Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis-enhancing properties of psoriatic serum

C. N. Ellis, Sewon Kang, R. C. Grekin, J. J. Voorhees, J. Silva

Research output: Contribution to journalArticle

Abstract

Using a Boyden chamber technic, we measured the directed chemotaxis of polymorphonuclear leukocytes obtained from control subjects or psoriasis patients when the leukocytes were placed in sera obtained form control subjects or psoriasis patients. The samples from patients were obtained before therapy and after 2 and 4 weeks of etretinate administration. Compared with control sera, the sera from seven untreated psoriasis patients significantly enhanced the chemotaxis of polymorphonuclear leukocytes from control subjects toward a chemotaxin (p

Original languageEnglish (US)
Pages (from-to)437-443
Number of pages7
JournalJournal of the American Academy of Dermatology
Volume13
Issue number3
StatePublished - 1985
Externally publishedYes

Fingerprint

Leukocyte Chemotaxis
Etretinate
Neutrophils
Psoriasis
Chemotaxis
Serum
Forms and Records Control
Chemotactic Factors
Therapeutics
Leukocytes

ASJC Scopus subject areas

  • Dermatology

Cite this

Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis-enhancing properties of psoriatic serum. / Ellis, C. N.; Kang, Sewon; Grekin, R. C.; Voorhees, J. J.; Silva, J.

In: Journal of the American Academy of Dermatology, Vol. 13, No. 3, 1985, p. 437-443.

Research output: Contribution to journalArticle

@article{83a3a9816a73498396e3691a58159cb5,
title = "Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis-enhancing properties of psoriatic serum",
abstract = "Using a Boyden chamber technic, we measured the directed chemotaxis of polymorphonuclear leukocytes obtained from control subjects or psoriasis patients when the leukocytes were placed in sera obtained form control subjects or psoriasis patients. The samples from patients were obtained before therapy and after 2 and 4 weeks of etretinate administration. Compared with control sera, the sera from seven untreated psoriasis patients significantly enhanced the chemotaxis of polymorphonuclear leukocytes from control subjects toward a chemotaxin (p",
author = "Ellis, {C. N.} and Sewon Kang and Grekin, {R. C.} and Voorhees, {J. J.} and J. Silva",
year = "1985",
language = "English (US)",
volume = "13",
pages = "437--443",
journal = "Journal of the American Academy of Dermatology",
issn = "0190-9622",
publisher = "Mosby Inc.",
number = "3",

}

TY - JOUR

T1 - Etretinate therapy reduces polymorphonuclear leukocyte chemotaxis-enhancing properties of psoriatic serum

AU - Ellis, C. N.

AU - Kang, Sewon

AU - Grekin, R. C.

AU - Voorhees, J. J.

AU - Silva, J.

PY - 1985

Y1 - 1985

N2 - Using a Boyden chamber technic, we measured the directed chemotaxis of polymorphonuclear leukocytes obtained from control subjects or psoriasis patients when the leukocytes were placed in sera obtained form control subjects or psoriasis patients. The samples from patients were obtained before therapy and after 2 and 4 weeks of etretinate administration. Compared with control sera, the sera from seven untreated psoriasis patients significantly enhanced the chemotaxis of polymorphonuclear leukocytes from control subjects toward a chemotaxin (p

AB - Using a Boyden chamber technic, we measured the directed chemotaxis of polymorphonuclear leukocytes obtained from control subjects or psoriasis patients when the leukocytes were placed in sera obtained form control subjects or psoriasis patients. The samples from patients were obtained before therapy and after 2 and 4 weeks of etretinate administration. Compared with control sera, the sera from seven untreated psoriasis patients significantly enhanced the chemotaxis of polymorphonuclear leukocytes from control subjects toward a chemotaxin (p

UR - http://www.scopus.com/inward/record.url?scp=0021810772&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021810772&partnerID=8YFLogxK

M3 - Article

C2 - 4056118

AN - SCOPUS:0021810772

VL - 13

SP - 437

EP - 443

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

SN - 0190-9622

IS - 3

ER -